financetom
Business
financetom
/
Business
/
Air taxi firm Vertical says Mudrick to covert some notes to equity, extend repayment deadline
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Air taxi firm Vertical says Mudrick to covert some notes to equity, extend repayment deadline
Nov 25, 2024 2:40 AM

By Abhijith Ganapavaram

(Reuters) - UK-based Vertical Aerospace ( EVTWF ) said on Monday that investor Mudrick Capital has agreed to convert 50% of its outstanding convertible debt notes to equity and extend the repayment date on the rest to December 2028, giving the cash-strapped air-taxi maker financial breathing room.

Mudrick will also commit $25 million in upfront funding in Vertical's next equity round and an additional $25 million backstop that will be reduced by any amounts raised from third parties, according to a press release being published later today.

The agreement will extend Vertical's cash runway into the fourth quarter of next year. The company had previously flagged ongoing concern doubts.

The term sheet includes an option for Vertical founder Stephen Fitzpatrick to invest a further $25 million into the company in the next year after he missed a previous deadline to inject money.

Mudrick earlier this month served a default notice to Vertical on convertible senior secured notes due 2026 after the company told the investor it might fall foul of certain covenants under their agreement.

Under the term sheet unveiled on Monday, approximately $130 million of Mudrick's convertible notes will be converted into equity at $2.75 per share, Vertical said.

The company is among a few eVTOL makers looking to upend urban travel by offering rides. However, the industry needs to tackle regulatory hurdles and overcome battery limitations. They also have to convince the public that their aircraft are safe.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With Nikola Shares Today?
What's Going On With Nikola Shares Today?
Jun 21, 2024
Nikola Corporation ( NKLA ) shares are gaining in the premarket session on Friday after ending yesterday’s session with a massive 31.5% dip. Yesterday, the company announced that its board of directors had approved a 1-for-30 reverse stock split. The reverse stock split will be effective as of June 24 at 4:01 p.m ET, and the stock will begin trading...
Market Chatter: Amazon Plans Launching Paid Premium AI-Driven Conversational Version of Alexa Service
Market Chatter: Amazon Plans Launching Paid Premium AI-Driven Conversational Version of Alexa Service
Jun 21, 2024
08:18 AM EDT, 06/21/2024 (MT Newswires) -- Amazon.com ( AMZN ) plans to introduce a conversational artificial intelligence, or AI, version of its Alexa service called Remarkable Alexa, with a premium version priced between $5 and $10 per month, Reuters reported Friday, citing people with direct knowledge of the company's plans. The project, dubbed internally as Banyan, has two tiers...
PVH Brand Tommy Hilfiger Becomes Official Lifestyle Apparel Partner for US SailGP Team
PVH Brand Tommy Hilfiger Becomes Official Lifestyle Apparel Partner for US SailGP Team
Jun 21, 2024
08:18 AM EDT, 06/21/2024 (MT Newswires) -- PVH (PVH) brand Tommy Hilfiger said Friday that it has entered a multi-year partnership with the US sailing team participating in the SailGP international sailing competition as their Official Lifestyle Apparel Partner. The clothing and accessories brand said the partnership will debut at the season five opening of the Sail Grand Prix in...
Bristol-Myers Squibb Says EMA Validates Application for Subcutaneous Opdivo
Bristol-Myers Squibb Says EMA Validates Application for Subcutaneous Opdivo
Jun 21, 2024
08:19 AM EDT, 06/21/2024 (MT Newswires) -- Bristol-Myers Squibb ( BMY ) said Friday the European Medicines Agency has validated its extension application to introduce subcutaneous administration of its cancer treatment, Opdivo. The extension application includes a new 600 mg/vial injection for various solid tumours as monotherapy, monotherapy maintenance following completion of nivolumab plus ipilimumab combination therapy, or in combination...
Copyright 2023-2026 - www.financetom.com All Rights Reserved